Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...
Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment When scientists sequence tumor DNA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results